Your Article Summary
See Latest ArticlesFDA Grants LUCAS 2 Chest Compression System 510(k) Clearance in the United States
Medtronic, 06/30/09
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc. , announced today that LUCAS 2, the next-generation LUCAS Chest Compression System, has been granted 510 market clearance by the U.S. Food and Drug Administration. Developed and manufactured by Jolife AB and distributed exclusively in the United States by Physio-Control, the LUCAS 2 is an automated, battery-powered device that is designed to give consistent, uninterrupted compressions to victims in cardiac arrest.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09